Mithil Gowda Suresh
Gastroenterology · Dover, DENPI 1164093282
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $461, 7.9 times the $59 reported in 2021. That places this record below the midpoint for gastroenterology clinicians in DE, where the typical reported total is $2,631.
Across 69 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$237
- AbbVie$218
- AstraZeneca$136
- Lilly USA, LLC$125
- Gilead$124
- Pfizer$114
- plus $588 from 15 others
What the payments were for
- Food & beverage$1,543100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 16 | $237 |
| AbbVie | 7 | $218 |
| AstraZeneca(2 entities) | 6 | $136 |
| Lilly USA, LLC | 1 | $125 |
| Gilead | 6 | $124 |
| Pfizer | 7 | $114 |
| Bayer | 5 | $91 |
| Grifols USA, LLC | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| GSK | 1 | $66 |
| Boehringer Ingelheim | 3 | $49 |
| Novartis | 2 | $34 |
| Merck | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMVOH$125
How this compares
$1,543 in reported general payments places this provider in the 35th percentile of 50 gastroenterology providers in Delaware.
Other gastroenterology in Dover
- Abhishek AgnihotriDover$28K
- Bhavin DaveDover$11K
- Michal BartelDover$6K
- Temitayo GboluajeDover$2K
- Muhammad HanafiDover$619
- Michael BrooksNewark$48K
- Richard CarusoLewes$13K
- Michael BassWilmington$11K
- Christopher RuffiniNeward$11K
- Jorge UribeNewark$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.